Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 123

1.

Birth weight, childhood body mass index and height and risks of endometriosis and adenomyosis.

Aarestrup J, Jensen BW, Ulrich LG, Hartwell D, Trabert B, Baker JL.

Ann Hum Biol. 2020 Mar 9:1-8. doi: 10.1080/03014460.2020.1727011. [Epub ahead of print]

PMID:
32151170
2.

Endogenous estradiol and inflammation biomarkers: potential interacting mechanisms of obesity-related disease.

Eldridge RC, Wentzensen N, Pfeiffer RM, Brinton LA, Hartge P, Guillemette C, Kemp TJ, Pinto LA, Trabert B.

Cancer Causes Control. 2020 Apr;31(4):309-320. doi: 10.1007/s10552-020-01280-6. Epub 2020 Feb 25.

PMID:
32100190
3.

Assessing Endogenous and Exogenous Hormone Exposures and Breast Development in a Migrant Study of Bangladeshi and British Girls.

Howland RE, Deziel NC, Bentley GR, Booth M, Choudhury OA, Hofmann JN, Hoover RN, Katki HA, Trabert B, Fox SD, Troisi R, Houghton LC.

Int J Environ Res Public Health. 2020 Feb 13;17(4). pii: E1185. doi: 10.3390/ijerph17041185.

4.

Relationship of Serum Progesterone and Progesterone Metabolites with Mammographic Breast Density and Terminal Ductal Lobular Unit Involution among Women Undergoing Diagnostic Breast Biopsy.

Hada M, Oh H, Fan S, Falk RT, Geller B, Vacek P, Weaver D, Shepherd J, Wang J, Fan B, Herschorn S, Brinton LA, Xu X, Sherman ME, Trabert B, Gierach GL.

J Clin Med. 2020 Jan 17;9(1). pii: E245. doi: 10.3390/jcm9010245.

5.

The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3).

Trabert B, Tworoger SS, O'Brien KM, Townsend MK, Fortner RT, Iversen ES, Hartge P, White E, Amiano P, Arslan AA, Bernstein L, Brinton LA, Buring JE, Dossus L, Fraser GE, Gaudet MM, Giles GG, Gram IT, Harris HR, Bolton JH, Idahl A, Jones ME, Kaaks R, Kirsh VA, Knutsen SF, Kvaskoff M, Lacey JV, Lee IM, Milne RL, Onland-Moret NC, Overvad K, Patel AV, Peters U, Poynter JN, Riboli E, Robien K, Rohan TE, Sandler DP, Schairer C, Schouten LJ, Setiawan VW, Swerdlow AJ, Travis RC, Trichopoulou A, van den Brandt PA, Visvanathan K, Wilkens LR, Wolk A, Zeleniuch-Jacquotte A, Wentzensen N; Ovarian Cancer Cohort Consortium (OC3).

Cancer Res. 2020 Mar 1;80(5):1210-1218. doi: 10.1158/0008-5472.CAN-19-2850. Epub 2020 Jan 13.

PMID:
31932455
6.

Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank.

Irvin SR, Weiderpass E, Stanczyk FZ, Brinton LA, Trabert B, Langseth H, Wentzensen N.

Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):636-642. doi: 10.1158/1055-9965.EPI-19-0675. Epub 2020 Jan 13.

PMID:
31932414
7.

Association of Powder Use in the Genital Area With Risk of Ovarian Cancer.

O'Brien KM, Tworoger SS, Harris HR, Anderson GL, Weinberg CR, Trabert B, Kaunitz AM, D'Aloisio AA, Sandler DP, Wentzensen N.

JAMA. 2020 Jan 7;323(1):49-59. doi: 10.1001/jama.2019.20079.

8.

Amount and Intensity of Leisure-Time Physical Activity and Lower Cancer Risk.

Matthews CE, Moore SC, Arem H, Cook MB, Trabert B, Håkansson N, Larsson SC, Wolk A, Gapstur SM, Lynch BM, Milne RL, Freedman ND, Huang WY, Berrington de Gonzalez A, Kitahara CM, Linet MS, Shiroma EJ, Sandin S, Patel AV, Lee IM.

J Clin Oncol. 2020 Mar 1;38(7):686-697. doi: 10.1200/JCO.19.02407. Epub 2019 Dec 26.

9.

Development and validation of circulating CA125 prediction models in postmenopausal women.

Sasamoto N, Babic A, Rosner BA, Fortner RT, Vitonis AF, Yamamoto H, Fichorova RN, Titus LJ, Tjønneland A, Hansen L, Kvaskoff M, Fournier A, Mancini FR, Boeing H, Trichopoulou A, Peppa E, Karakatsani A, Palli D, Grioni S, Mattiello A, Tumino R, Fiano V, Onland-Moret NC, Weiderpass E, Gram IT, Quirós JR, Lujan-Barroso L, Sánchez MJ, Colorado-Yohar S, Barricarte A, Amiano P, Idahl A, Lundin E, Sartor H, Khaw KT, Key TJ, Muller D, Riboli E, Gunter M, Dossus L, Trabert B, Wentzensen N, Kaaks R, Cramer DW, Tworoger SS, Terry KL.

J Ovarian Res. 2019 Nov 26;12(1):116. doi: 10.1186/s13048-019-0591-4.

10.

Reproductive and Hormonal Factors and Risk of Ovarian Cancer by Tumor Dominance: Results from the Ovarian Cancer Cohort Consortium (OC3).

Huang T, Townsend MK, Wentzensen N, Trabert B, White E, Arslan AA, Weiderpass E, Buring JE, Clendenen TV, Giles GG, Lee IM, Milne RL, Onland-Moret NC, Peters U, Sandler DP, Schouten LJ, van den Brandt PA, Wolk A, Zeleniuch-Jacquotte A, Tworoger SS.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):200-207. doi: 10.1158/1055-9965.EPI-19-0734. Epub 2019 Nov 12.

PMID:
31719062
11.

Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women's Health Initiative Observational Study.

Trabert B, Coburn SB, Falk RT, Manson JE, Brinton LA, Gass ML, Kuller LH, Rohan TE, Pfeiffer RM, Qi L, Stefanick ML, Wentzensen N, Anderson GL, Xu X.

Cancer Causes Control. 2019 Nov;30(11):1201-1211. doi: 10.1007/s10552-019-01233-8. Epub 2019 Sep 21.

PMID:
31542834
12.

Progesterone and Breast Cancer.

Trabert B, Sherman ME, Kannan N, Stanczyk FZ.

Endocr Rev. 2020 Apr 1;41(2). pii: bnz001. doi: 10.1210/endrev/bnz001.

PMID:
31512725
13.

Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER-Medicare data.

Michels KA, McNeel TS, Trabert B.

Gynecol Oncol. 2019 Nov;155(2):294-300. doi: 10.1016/j.ygyno.2019.08.032. Epub 2019 Sep 5.

PMID:
31495456
14.

High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium.

Peres LC, Mallen AR, Townsend MK, Poole EM, Trabert B, Allen NE, Arslan AA, Dossus L, Fortner RT, Gram IT, Hartge P, Idahl A, Kaaks R, Kvaskoff M, Magliocco AM, Merritt MA, Quirós JR, Tjonneland A, Trichopoulou A, Tumino R, van Gils CH, Visvanathan K, Wentzensen N, Zeleniuch-Jacquotte A, Tworoger SS.

Cancer Res. 2019 Oct 15;79(20):5442-5451. doi: 10.1158/0008-5472.CAN-19-1554. Epub 2019 Aug 28.

PMID:
31462430
15.

Population Frequency of Serous Tubal Intraepithelial Carcinoma (STIC) in Clinical Practice Using SEE-Fim Protocol.

Samimi G, Trabert B, Geczik AM, Duggan MA, Sherman ME.

JNCI Cancer Spectr. 2018 Dec 14;2(4):pky061. doi: 10.1093/jncics/pky061. eCollection 2018 Oct.

16.

Postmenopausal Androgen Metabolism and Endometrial Cancer Risk in the Women's Health Initiative Observational Study.

Michels KA, Brinton LA, Wentzensen N, Pan K, Chen C, Anderson GL, Pfeiffer RM, Xu X, Rohan TE, Trabert B.

JNCI Cancer Spectr. 2019 Sep;3(3):pkz029. doi: 10.1093/jncics/pkz029. Epub 2019 Apr 25.

PMID:
31321379
17.

Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: A Nordic population-based case-control study.

Trabert B, Troisi R, Grotmol T, Ekbom A, Engeland A, Gissler M, Glimelius I, Madanat-Harjuoja L, Sørensen HT, Tretli S, Gulbech Ording A, Bjørge T.

Int J Cancer. 2020 Mar 15;146(6):1523-1531. doi: 10.1002/ijc.32494. Epub 2019 Jun 20.

PMID:
31173648
18.

The influence of birth cohort and calendar period on global trends in ovarian cancer incidence.

Cabasag CJ, Arnold M, Butler J, Inoue M, Trabert B, Webb PM, Bray F, Soerjomataram I.

Int J Cancer. 2020 Feb 1;146(3):749-758. doi: 10.1002/ijc.32322. Epub 2019 Apr 30.

PMID:
30968402
19.

High prevalence of precocious menarche in Puerto Barrios, Guatemala.

Torres-González E, López G, Trabert B, Argueta V, Gharzouzi E, Dean M, Orozco R.

Am J Obstet Gynecol. 2019 Aug;221(2):162-163. doi: 10.1016/j.ajog.2019.03.013. Epub 2019 Mar 26. No abstract available.

PMID:
30926264
20.

Circulating inflammation markers and colorectal adenoma risk.

Huang WY, Berndt SI, Shiels MS, Katki HA, Chaturvedi AK, Wentzensen N, Trabert B, Kemp TJ, Pinto LA, Hildesheim A, Rothman N, Purdue MP.

Carcinogenesis. 2019 Jul 6;40(6):765-770. doi: 10.1093/carcin/bgz027.

PMID:
30753331

Supplemental Content

Loading ...
Support Center